1 Fujii K,Nagata C,Nakamura K,et al.Prevalence of tinnitus in community-dwelling Japanese adults[J].Journal of Epidemiology,2011,21:299.

2 Nondahl DM,Cruickshanks KJ,Huang GH,et al.Tinnitus and its risk factors in the Beaver Dam offspring study[J].International Journal of Audiology,2011,50:313.

3 Shargorodsky J,Curhan GC,Farwell WR.Prevalence and characteristics of tinnitus among US adults[J].American Journal of Medicine,2010,123:711.

4 Holmes S,Padgham ND.“Ringing in the ears”':narrative review of tinnitus and its impact[J].Biological Research for Nursing,2011,13:97.

5 Hoekstra CE,Rynja SP,van Zanten GA,et al.Anticonvulsants for tinnitus[J].Cochrane Database of Systematic Reviews,2011(7):CD007960.

6 Enrico P,Sirca D,Mereu M.Antioxidants,minerals,vitamins,and herbal remedies in tinnitus therapy[J].Progress in Brain Research,2007,166:323.

7 Robinson S.Antidepressants for treatment of tinnitus[J].Progress in Brain Research,2007,166:263.

8 Darlington CL,Smith PF.Drug treatments for tinnitus[J].Progress in Brain Research,2007,166:249.

9 Patterson MB,Balough BJ.Review of pharmacological therapy for tinnitus[J].International Tinnitus Journal,2006,12:149.

10 Smith PF,Darlington CL.Drug treatments for subjective tinnitus:serendipitous discovery versus rational drug design[J].Current Opinion in Investigational Drugs,2005,6:712.

11 Hilton M,Stuart E.Ginkgo biloba for tinnitus[J].Cochrane Database of Systematic Reviews,2004(2):CD003852.

12 Simpson JJ,Davies WE.Recent advances in the pharmacological treatment of tinnitus[J].Trends in Pharmacological Sciences,1999,20:12.

13 Dobie RA.A review of randomized clinical trials in tinnitus[J].Laryngoscope,1999,109:1 202.

14 Golm D,Schmidt-Samoa C,Dechent P,et al.Neural correlates of tinnitus related distress:An fMRI-study[J].Hearing Research,2012(In press).

15 Lorenz I,Müller N,Schlee W,et al.Loss of alpha power is related to increased gamma synchronization-A marker of reduced inhibition in tinnitus[J]?Neuroscience Letters,2009,453:225.

16 Lanting C,de Kleine E,van Dijk P.Neural activity underlying tinnitus generation:Results from PET and fMRI[J].Hearing Research,2009,255:1.

17 Arbanas G,Arbanas D,Dujam K.Adverse effects of benzodiazepines in psychiatric outpatients[J].Psychiatria danubina,2009,21:103.

18 Noyes R Jr,DuPont RL Jr,Pecknold JC,et al.Alprazolam in panic disorder and agoraphobia:results from a multicenter trial.II.Patient acceptance,side effects,and safety[J].Archives of General Psychiatry,1988,45:423.

19 Galanter M.The American Psychiatric publishing textbook of substance abuse treatment(4ed.)[M].America:American Psychiatric Publishing,2008,222~231.

20 Verster JC,Volkerts ER.Clinical pharmacology,clinical efficacy,and behavioral toxicity of alprazolam:a review of the literature[J].CNS Drug Rev,2004,10:45.

21 Rosebush PI,Mazurek MF.Catatonia after benzodiazepine withdrawal[J].Journal of Clinical Psychopharmacology,1996,16:315.

22 Work Group on Panic Disorder.APA Practice Guideline for the Treatment of Patients With Panic Disorder,Second Edition".http://psychiatryonline.org/content.aspx?bookid=

28 &sectionid=1680635,2009.

23 Rush CR,Higgins ST,Bickel WK,et al.Abuse liability of alprazolam relative to other commonly used benzodiazepines:a review[J].Neuroscience&Biobehavioral Reviews,1993,17:277.

24 Romach MK,Somer GR,Sobell LC,et al.Characteristics of long-term alprazolam users in the community[J].Journal of Clinical Psychopharmacology,1992,12:316.

25 Raison C.Expert Q&A:What are the long-term brain effects of Xanax?http://www.cnn.com/2010/HEALTH/expert.q.a/03/23/xanax.long.term.use.raison/index.html.

26 Johnson RM,Brummett R,Schleuning A.Use of alprazolam for relief of tinnitus[J].A double-blind study.Archives of Otolaryngology-Head and Neck Surgery,1993,119:842.

27 Jalali MM,Kousha A,Naghavi SE,et al.The effects of alprazolam on tinnitus:a cross-over randomized clinical trial[J].Medical Science Monitor,2009,15:PI55.

28 Shim H,Song S,Choi A,et al.Comparison of various treatment modalities for acute tinnitus[J].Laryngoscope,2011,121:2 619.

29 Tampi RR,Muralee S,Weder ND,et al.Comprehensive review of psychiatry[M].Philadelphia,PA:Wolters Kluwer/Lippincott Williams&Wilkins Health,2008,226~227.

30 Pavuluri MN,Janicak PG,Marder SR.Principles and practice of psychopharmacotherapy[M].5th ed.Philadelphia,PA:Wolters Kluwer Health/Lippincott Williams&Wilkins,2010,535~540.

31 Miller LG.Chronic benzodiazepine administration:from the patient to the gene[J].Journal of Clinical Pharmacology,1991,31:492.

32 Pomara N,Willoughby LM,Ritchie JC,et al.Nemeroff CB.Interdose elevation in plasma cortisol during chronic treatment with alprazolam but not lorazepam in the elderly[J].Neuropsychopharmacology,2004,29:605.

33 Roy-Byrne P,Russo J,Pollack M,et al.Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder[J].Psychological Medicine,2003,33:511.

34 US.Food and Drug Administration.XANAX?alprazolam tablets,USP.http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/018276s0451b1.pdf

35 Ciraulo DA,Barnhill JG,Ciraulo AM,et al.Parental alcoholism as a risk factor in benzodiazepine abuse:apilot study[J].American Journal of Psychiatry,1089,146:1 333.

36 Juergens SM,Morse RM.Alprazolam dependence in seven patients[J].American Journal of Psychiatry,1988,145:625.

37 US Drug Enforcement Administration.Drug Information:B.http://www.justice.gov/dea/concern/b.html#2.

38 Romach M,Busto U,Somer G,et al.Clinical aspects of chronic use of alprazolam and lorazepam[J].American Journal of Psychiatry,1995,152:1 161.